Will avilamycin convert Ziracine into zerocine?

被引：10

作者：

Courvalin, P ^{[1
]}

机构：

[1] Inst Pasteur, Paris, France

来源：

EMERGING INFECTIOUS DISEASES | 2000年 / 6卷 / 05期

关键词：

D O I：

10.3201/eid0605.000521

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：558 / 558

页数：1

共 8 条

[1] Association between decreased susceptibility to a new antibiotic for treatment of human diseases, everninomicin (SCH 27899), and resistance to an antibiotic used for growth promotion in animals, avilamycin [J].

Aarestrup, FM .

MICROBIAL DRUG RESISTANCE, 1998, 4 (02) :137-141

[2]

ADRIAN PV, 1999, P 39 INT C ANT AG CH

[3]

Jones Ronald N., 1995, Clin Microbiol Infect, V1, P35, DOI 10.1111/j.1469-0691.1995.tb00022.x

[4] Evernimicin binds exclusively to the 50S ribosomal subunit and inhibits translation in cell-free systems derived from both gram-positive and gram-negative bacteria [J].

McNicholas, PM ;

Najarian, DJ ;

Mann, PA ;

Hesk, D ;

Hare, RS ;

Shaw, KJ ;

Black, TA .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (05) :1121-1126

[5] Transmission of VanA-type vancomycin-resistant enterococci and vanA resistance elements between chicken and humans at avoparcin-exposed farms [J].

Simonsen, GS ;

Haaheim, H ;

Dahl, KH ;

Kruse, H ;

Lovseth, A ;

Olsvik, O ;

Sundsfjord, A .

MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1998, 4 (04) :313-318

[6]

Swann M., 1969, Report of the joint committee on the use of antibiotics in animal husbandry and veterinary medicine

[7] Use of antimicrobial growth promoters in food animals and Enterococcus faecium resistance to therapeutic antimicrobial drugs in Europe [J].

Wegener, HC ;

Aarestrup, FM ;

Jensen, LB ;

Hammerum, AM ;

Bager, F .

EMERGING INFECTIOUS DISEASES, 1999, 5 (03) :329-335

[8]

WEINSTEIN MJ, 1965, ANTIMICROB AGENTS CH, V9, P24

← 1 →